Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice

Neurobiology of Disease

Volumn 8, Issue 6, 2001, Pages 982-992

  Kulnane, Laura Shapiro ^a   Lamb, Bruce T ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTIBODY; APOLIPOPROTEIN E; CLUSTERIN; GENE PRODUCT; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; INFLAMMATION; MALE; MOUSE; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SPECIES DIFFERENCE; TRANSGENIC MOUSE; YEAST;

EID: 0035664046     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0446     Document Type: Article

References (65)

1. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia
2. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction
3. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
4. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice
5. Neurodegenerative Alzheimer-like pathology in PDAPP 717V → F transgenic mice
6. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta
7. Axonal loss from the olfactory tracts in Alzheimer's disease
8. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease
9. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up
10. Microglial response to amyloid plaques in APPsw transgenic mice
11. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
12. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebro-vascular amyloid protein
13. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
14. Amyloid β protein (Aβ) in Alzheimer's disease brain
15. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
16. A novel method for making nested deletions and its application for sequencing of a 300 kb region of the human APP locus
17. The DNA sequence of human chromosome 21. The chromosome 21 mapping and sequencing consortium
18. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain
19. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells
20. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
21. Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: Evidence that an initially deposited Aβ species is Aβ1-42(43)
22. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down syndrome
23. Transgenic mouse models of Alzheimer's disease
24. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau
25. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
26. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies
27. Cholinergic structures and neuropathologic alterations in he olfactory bulb of Alzheimer's disease brain samples
28. Beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease
29. Olfactory centres in Alzheimer's disease: Olfactory bulb is involved in early Braak's stages
30. Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: Increased immunoreactivity in Alzheimer's disease
31. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice
32. YAC transgenics and the study of genetics and human disease
33. Altered metabolism of familial Alzheimer's disease-linked precursor protein variants in yeast artificial chromosome transgenic mice
34. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice
35. Sequence of deposition of heterogeneous amyloid β-peptides and APOE in Down syndrome: Implication for initial events in amyloid plaque formation
36. Exploring the etiology of Alzheimer disease using molecular genetics
37. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex
38. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
39. Olfactory function in young adolescents with Downs's syndrome
40. Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases
41. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgemc mice: Synaptotoxicity without plaque formation
42. A pathogenetic mutation for probabte Alzheimer's disease in the APP gene at the N-terminus of β-amyloid
43. Olfactory dysfunction in Down's Syndrome
44. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons
45. Atrophic cell processes of large motor neurons in the anterior horn in amyotrophic lateral sclerosis: Observation with silver impregnation method
46. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
47. Odor memory in normal aging and Alzheimer's disease
48. Alteration of neuritic cytoarchitecture in Alzheimer disease
49. The value of transgenic models for the study of neurodegenerative diseases
50. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease
51. The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse
52. Apoptosis of bcl-x-deficient telencephalic cells in vitro
53. Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester
54. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
55. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein
56. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system
57. Genetic factors in the genesis of Alzheimer's disease
58. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated form of neurofilaments in situ
59. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
60. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
61. The olfactory bulb in Alzheimer disease: A morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction
62. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
63. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques
64. A neuronal antigen in the brains of Alzheimer patients
65. β-Amyloid and the pathogenesis of Alzheimer's disease